See more : CORESTATE Capital Holding S.A. (0RVJ.L) Income Statement Analysis – Financial Results
Complete financial analysis of Binovi Technologies Corp. (BNVIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Binovi Technologies Corp., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Taiheiyo Cement Corporation (THYCY) Income Statement Analysis – Financial Results
- PT Surya Fajar Capital Tbk (SFAN.JK) Income Statement Analysis – Financial Results
- Inovalis Real Estate Investment Trust (INO-UN.TO) Income Statement Analysis – Financial Results
- Orchid Pharma Limited (ORCHPHARMA.NS) Income Statement Analysis – Financial Results
- Etablissements Maurel & Prom S.A. (0F6L.L) Income Statement Analysis – Financial Results
Binovi Technologies Corp. (BNVIF)
About Binovi Technologies Corp.
Binovi Technologies Corp. develops, manufactures, and commercializes visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. Its products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company's product under development include Binovi Agile; and Binovi Connect, a web-based video conferencing solution that connects consumers to vision care professionals. The company was formerly known as Eyecarrot Innovations Corp. and changed its name to Binovi Technologies Corp. in June 2020. Binovi Technologies Corp. is based in Vancouver, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 186.35K | 728.48K | 687.21K | 666.72K | 98.89K | 97.02K | 67.63K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 54.52K | 205.52K | 102.06K | 290.24K | 13.43K | 20.82K | 7.53K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 131.83K | 522.96K | 585.15K | 376.48K | 85.46K | 76.20K | 60.10K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 70.74% | 71.79% | 85.15% | 56.47% | 86.42% | 78.54% | 88.86% | 0.00% | 0.00% | 0.00% |
| Research & Development | 125.24K | 467.13K | 484.05K | 439.78K | 187.89K | 238.63K | 916.36K | 178.52K | 74.40K | 0.00 |
| General & Administrative | 3.27M | 5.34M | 6.02M | 3.69M | 2.42M | 3.80M | 2.44M | 516.59K | 345.74K | 146.49K |
| Selling & Marketing | 814.21K | 2.11M | 487.58K | 371.89K | 0.00 | 205.24K | 306.62K | 168.00K | 107.53K | 6.68K |
| SG&A | 4.08M | 7.45M | 6.51M | 4.07M | 2.42M | 4.00M | 2.75M | 684.59K | 453.28K | 153.17K |
| Other Expenses | 1.17M | -795.60K | -1.06M | -113.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 5.37M | 8.69M | 7.14M | 4.70M | 2.76M | 4.40M | 3.77M | 864.70K | 528.47K | 153.17K |
| Cost & Expenses | 5.43M | 8.90M | 7.24M | 4.99M | 2.78M | 4.42M | 3.78M | 864.70K | 528.47K | 153.17K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 83.12K | 52.51K | 40.73K | 10.98K | 7.61K | 6.38K | 15.26K | 1.28K | 644.00 | 0.00 |
| Depreciation & Amortization | 1.17M | 773.14K | 185.03K | 159.46K | 159.49K | 159.49K | 107.14K | 1.59K | 793.00 | 0.00 |
| EBITDA | -15.13M | -8.32M | -7.46M | -4.28M | -2.55M | -4.17M | -3.60M | -837.75K | -527.68K | -153.17K |
| EBITDA Ratio | -8,120.15% | -1,124.81% | -1,080.02% | -642.28% | -2,547.63% | -4,293.09% | -5,329.21% | 0.00% | 0.00% | 0.00% |
| Operating Income | -5.24M | -8.97M | -7.61M | -4.44M | -2.68M | -4.32M | -3.71M | -864.70K | -528.47K | -153.17K |
| Operating Income Ratio | -2,811.32% | -1,230.94% | -1,106.94% | -666.20% | -2,708.92% | -4,457.47% | -5,487.64% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -11.14M | -856.82K | -1.14M | -331.30K | -34.05K | -11.06K | -132.30K | -1.28K | -172.23K | 0.00 |
| Income Before Tax | -16.38M | -9.03M | -7.69M | -4.77M | -2.71M | -4.34M | -3.84M | -865.97K | -700.70K | -153.17K |
| Income Before Tax Ratio | -8,790.19% | -1,239.34% | -1,118.89% | -715.89% | -2,743.35% | -4,468.87% | -5,683.26% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -743.09K | -1.02M | -102.45K | 7.61K | 6.38K | 15.26K | 0.00 | 644.00 | -7.13K |
| Net Income | -16.38M | -9.03M | -7.69M | -4.77M | -2.71M | -4.34M | -3.84M | -865.97K | -700.70K | -146.03K |
| Net Income Ratio | -8,790.19% | -1,239.34% | -1,118.89% | -715.89% | -2,743.35% | -4,468.87% | -5,683.26% | 0.00% | 0.00% | 0.00% |
| EPS | -0.90 | -1.07 | -4.23 | -4.76 | -4.07 | -7.87 | -8.56 | -5.13 | -4.88 | -1.13 |
| EPS Diluted | -0.90 | -1.07 | -4.23 | -4.76 | -4.07 | -7.87 | -8.56 | -5.13 | -4.88 | -1.13 |
| Weighted Avg Shares Out | 18.15M | 8.40M | 1.82M | 1.00M | 666.20K | 550.86K | 449.00K | 168.72K | 143.72K | 129.62K |
| Weighted Avg Shares Out (Dil) | 18.15M | 8.40M | 1.82M | 1.00M | 666.20K | 550.86K | 449.00K | 168.72K | 143.72K | 129.62K |
Binovi Completes Motion Tracking Software Acquisition
Binovi Technologies to buy vision therapy firm Samurai Motion Tracking in a C$2.5M all-stock deal
Binovi to Acquire Computer Aided Vision Therapy (CAVT)
Binovi Technologies expands its global reseller network with a partnership with Sport-Orthèse
Binovi Appoints Dr. Michael Gallaway to the Binovi Scientific Advisory Board
Source: https://incomestatements.info
Category: Stock Reports